145 related articles for article (PubMed ID: 3944485)
1. Nasal carriage of toxigenic Staphylococcus aureus and prevalence of serum antibody to toxic-shock-syndrome toxin 1 in Utah.
Jacobson JA; Kasworm EM; Crass BA; Bergdoll MS
J Infect Dis; 1986 Feb; 153(2):356-9. PubMed ID: 3944485
[No Abstract] [Full Text] [Related]
2. Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.
Parsonnet J; Hansmann MA; Seymour JL; Delaney ML; Dubois AM; Modern PA; Jones MB; Wild JE; Onderdonk AB
BMC Infect Dis; 2010 Aug; 10():249. PubMed ID: 20731864
[TBL] [Abstract][Full Text] [Related]
3. Frequency of nasal and wound isolates of Staphylococcus aureus associated with TSST-1 production in Jordanian population.
Daghistani HI; Issa AA; Shehabi AA
FEMS Immunol Med Microbiol; 2000 Feb; 27(2):95-8. PubMed ID: 10640602
[TBL] [Abstract][Full Text] [Related]
4. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
Park JY; Kim JS; Woo H
Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
[TBL] [Abstract][Full Text] [Related]
6. Immune response to toxic-shock-syndrome toxin-1 (TSST-1) and to staphylococcal enterotoxins A, B and C in Staphylococcus aureus infections.
Kunstmann G; Schröder E; Hasbach H; Pulverer G
Zentralbl Bakteriol; 1989 Oct; 271(4):486-92. PubMed ID: 2818798
[TBL] [Abstract][Full Text] [Related]
7. Toxin involvement in toxic shock syndrome.
Crass BA; Bergdoll MS
J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus nasal carriage among healthcare workers in Kisangani, the Democratic Republic of the Congo.
De Boeck H; Vandendriessche S; Hallin M; Batoko B; Alworonga JP; Mapendo B; Van Geet C; Dauly N; Denis O; Jacobs J
Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1567-72. PubMed ID: 25931131
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of toxic shock syndrome toxin-1 producing Staphylococcus aureus and the anti TSST-1 serostatus of hospital personnel in Nigeria.
Olusanya O; Naidu AS
East Afr Med J; 1991 Jul; 68(7):507-14. PubMed ID: 1756702
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB
J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains.
Hoeger PH; Lenz W; Boutonnier A; Fournier JM
J Infect Dis; 1992 Jun; 165(6):1064-8. PubMed ID: 1583324
[TBL] [Abstract][Full Text] [Related]
12. Low incidence of toxic shock syndrome in children with staphylococcal infection.
Jacobson JA; Kasworm EM; Reiser RF; Bergdoll MS
Am J Med Sci; 1987 Dec; 294(6):403-7. PubMed ID: 3425588
[TBL] [Abstract][Full Text] [Related]
13. Association of high levels of serum antibody to staphylococcal toxic shock antigen with nasal carriage of toxic shock antigen-producing strains of Staphylococcus aureus.
Ritz HL; Kirkland JJ; Bond GG; Warner EK; Petty GP
Infect Immun; 1984 Mar; 43(3):954-8. PubMed ID: 6698614
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus nasal carriage in rheumatoid arthritis: antibody response to toxic shock syndrome toxin-1.
Tabarya D; Hoffman WL
Ann Rheum Dis; 1996 Nov; 55(11):823-8. PubMed ID: 8976639
[TBL] [Abstract][Full Text] [Related]
15. The effect of Staphylococcus aureus carriage in late pregnancy on antibody levels to staphylococcal toxins in cord blood and breast milk.
Harrison LM; Morris JA; Lauder RM; Telford DR
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):137-43. PubMed ID: 18665847
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of producers of enterotoxins and toxic shock syndrome toxin-1 among Staphylococcus aureus strains isolated from atopic dermatitis lesions.
Akiyama H; Toi Y; Kanzaki H; Tada J; Arata J
Arch Dermatol Res; 1996 Jun; 288(7):418-20. PubMed ID: 8818194
[No Abstract] [Full Text] [Related]
17. Risk involvement with Staphylococcus aureus exotoxins among pyogenic skin infections with special reference to toxic shock syndrome.
Naidu S; Rajyalakshmi K; Naidu AS
Acta Microbiol Hung; 1989; 36(1):7-12. PubMed ID: 2603647
[TBL] [Abstract][Full Text] [Related]
18. Frequency of superantigen encoding genes of Staphylococcus aureus isolates collected from multiple sclerosis (MS) patients and nasal carriers.
Sadeghi J; Alizadeh N; Ahangar Oskouei M; Laghusi D; Savadi Oskouei D; Nikanfar M; Seyyed Mousavi MN
Microb Pathog; 2019 Feb; 127():316-319. PubMed ID: 30553909
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains.
Lozano C; Gómez-Sanz E; Benito D; Aspiroz C; Zarazaga M; Torres C
Int J Med Microbiol; 2011 Aug; 301(6):500-5. PubMed ID: 21570348
[TBL] [Abstract][Full Text] [Related]
20. [Study on production of toxic shock syndrome toxin in Staphylococcus aureus isolated from clinical specimens].
Kawakami H; Yamada Y
Kansenshogaku Zasshi; 1986 Feb; 60(2):133-40. PubMed ID: 3090164
[No Abstract] [Full Text] [Related]
[Next] [New Search]
